Discover
CLRB
Cellectar Biosciences, Inc.
2.83
2 x 2.03
2 x 3.46
bid
ask
+
0.05
1.80%
2 @ 04:00 PM
2.60 -0.23 (8.13%)
| Ytd | -4.07% | |
| 1y | -41.77% |
2.70
day range
2.89
2.20
52 week range
6.52
| Open | 2.79 | Prev Close | 2.78 | Low | 2.70 | High | 2.89 | Mkt Cap | 22.62M |
| Vol | 92.15K | Avg Vol | 1.05M | EPS | -5.38 | P/E | N/A | Forward P/E | -0.10 |
| Beta | 1.01 | Short Ratio | 8.34 | Inst. Own | 34.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.80 | 200-d Avg | 3.37 | 1yr Est | 5.67 |
| Income Statement | |||
| Operating Expenses | 5.79M | ||
| Research and Development Expense | 3.01M | ||
| Selling, General and Administrative Expense | 2.79M | ||
| Operating Income | -5.79M | ||
| Net Income | -5.65M | ||
| Net Income Common Stock | -5.65M | ||
| Net Income Common Stock (USD) | -5.65M | ||
| Consolidated Income | -5.65M | ||
| Earnings per Basic Share | -1.33 | ||
| Earnings per Basic Share (USD) | -1.33 | ||
| Earnings per Diluted Share | -1.33 | ||
| Earning Before Interest & Taxes (EBIT) | -5.65M | ||
| Earning Before Interest & Taxes (USD) | -5.65M | ||
| Weighted Average Shares | 4.24M | ||
| Weighted Average Shares Diluted | 4.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.35M | ||
| Cash and Equivalents (USD) | 8.35M | ||
| Current Assets | 9.27M | ||
| Property, Plant & Equipment Net | 1.82M | ||
| Total Assets | 11.12M | ||
| Total Debt | 1.53M | ||
| Current Liabilities | 4.87M | ||
| Debt Non-Current | 1.53M | ||
| Total Liabilities | 6.40M | ||
| Accumulated Retained Earnings (Deficit) | -274.79M | ||
| Shareholders Equity | 3.34M | ||
| Shareholders Equity (USD) | 3.34M | ||
| Assets Non-Current | 1.85M | ||
| Total Debt (USD) | 1.53M | ||
| Liabilities Non-Current | 1.53M | ||
| Trade and Non-Trade Payables | 4.72M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -110.02K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.85M | ||
| Capital Expenditure | -3.38K | ||
| Net Cash Flow from Investing | -3.38K | ||
| Net Cash Flow from Operations | -4.85M | ||
| Share Based Compensation | 451.87K | ||